维持性透析患者安全用药知信行现状调查及相关因素分析
|
|
魏珊, 纪鸥洋, 陈志豪, 黄泽慧, 李璞, 方均燕, 刘英莉
|
A prevalence study on knowledge, attitude, belief and practice of safe medication and analysis of related factors in dialysis patients
|
|
WEI Shan, JI Ouyang, CHEN Zhihao, HUANG Zehui, LI Pu, FANG Junyan, LIU Yingli
|
|
表3 维持性透析患者安全用药KAP得分单因素线性回归分析
|
Tab 3 Univariable linear regression analysis of KAP scores for safe medication in the maintenance dialysis patients
|
|
| Variable | Value/n | Partial regression coefficient | Standardized regression coefficient | t value | P value |
|---|
| Number of comorbidities | 6.37±2.17 | -2.378 | -2.278 | -3.939 | 0.000 | | Number of medications | 7.48±2.66 | 0.233 | 0.033 | 0.454 | 0.650 | | Number of oral tablets | 17.30±9.37 | 0.102 | 0.052 | 0.703 | 0.483 | | Number of medications for regulating calcium and phosphorus metabolism | 1.94±1.23 | -2.227 | -0.148 | -2.040 | 0.043 | | Number of anemic medications | 1.04±0.65 | 0.117 | 0.004 | 0.055 | 0.956 | | Number of MRPs | 3.10±1.49 | -4.011 | -0.323 | -4.636 | 0.000 |
|
|
|